05/02/2016 22:04:20 Cookie Policy +44 (0) 207 0700 961 Free Membership Login

You’ve just added your first Follow! This is a brand new feature that will be at the core of several new tools and personalized information feeds that are coming soon.

You can see your current Follow list as a Monitor list here.

Please continue to add stocks to your Follow list so that when the new tools and feeds roll out, you’ll immediately get to make use of them! We will alert early adopters of the Follow list to these new features first.

Aortech Share Chat (AOR)

Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 27.50p 26.00p 29.00p 27.50p 27.50p 27.50p 13,200 07:38:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.8 -0.3 -7.7 - 1.33

Aortech Share Discussion Threads

Showing 3251 to 3272 of 3275 messages
Post New Message
Chat Pages: 131  130  129  128  127  126  125  124  123  122  121  120  >>
DateSubjectAuthorDiscuss
22/1/2016
13:49
bbr391 - You seems a knowledgeable sort of guy...have you heard how the heart valve project is going?gac141
21/1/2016
23:44
Still ongoing .bbr391
19/1/2016
09:18
Anyone have any ideas on the legal action status please?semper vigilans
06/12/2015
14:56
Oh yes and when we all thought the writing was on the wall and Aortech was bust how much of your money did you chance David? This money saved Aortech....gac141
06/12/2015
13:04
I see Xmas coming early for loan note holders. Shocking really, but to be expected from AIM listed companies these days.cocker
27/11/2015
12:40
Very disappointing revenue figures below last years interims Lets hope litigation is not being used as an excuse for poor sales focus. Have to say I believe Harrogate has summed up the current situation very well in his previous post Let us hope the directors are fully focussed on unlocking shareholder value I do not think there has been any change in that potential value but we do need to stay in business long enough to unlock that value ! No more banana skins would be appreciatedspurious
27/11/2015
11:15
Aortech issued its Interim results and reported that trading for the 6 months to 30 September 2015 was in line with expectations and that after amortisation and exceptionals the reported operating loss was $193,000. Much of the Chairman’s statement was taken with describing the potential for the set up of a new company to take forward AorTech’s heart valve technology - could this potentially unlock some of the value here in this AIM minnow, valued at just £1.2 million? See more at: hTTp://tinyurl.com/o95ehwxinvestorschampion
18/11/2015
11:12
why the sudden drop here, I wonder. No news about, no heavy selling that I'm aware of. MMs trying clear out weak holders before some good news is announced? Or have they got wind of bad news? Possibly it's neither.. just random market movements.shrout
25/10/2015
08:30
Yes......25th October seems to be a significant date!tadders2
25/10/2015
08:05
AorTech International PLC v. Folda The case against the Ex . Should provide our next uplift . The future is bright as long as the current board play the cards right . Good luck all And Maybbr391
16/9/2015
18:10
Hi Gents - thanks for the notes - I am perhaps always as a long standing shareholder ( 1999) just too beaten up to believe all that yet - Hope you are right/ Thanksharrogate
16/9/2015
10:08
Harrogate As a fellow shareholder of longstanding (some may say long suffering)I understand your caution I am not noted for wild bouts of optimism particularly with Aor however I do recognise a fundamental shift both in sentiment and in what has been achieved over the last 12 months. I feel we are at an inflexion point for the share price which as we all know tends to anticipate events well in advance 12 month results pointed to a profitable stable company now crucially happy with its renegotiated relationship with Biomerics, confident in a ring fenced litigation process and now fully focused in releasing shareholder value through expanding its licencees and at long last attempting to realise the massive opportunity offered by its heart valve( backed by extensive patent protection). Let us wait for the evidence but the signs are already there. Once the evidence is out there the share price will imo be north of £1 and an opportunity missed. The tiny £2m current market cap imo offers a risk/reward ratio substantially in favour of the investor. That value is what I am trying to highlight.It would seem I am not alone Let us hope I am right Regards SPspurious
16/9/2015
09:13
Harrogate You are correct that there would appear to be masses of work to do, but reading the last statement would suggest that the outcome of that work should be positive. The IP position is better than 1999, there are 3 generations of patent filings since then some very recent. The key to value would seem to be can they identify a credible team to take the project forward?landy90
16/9/2015
08:35
On Tip TV today.. After the crash Zak identifies the top 10 shares to buy TODAY for the autumn in his new book published 1st September. Get your free copy HERE Aortech International (AOR): 70p Price Channel Destination It has not exactly been a pleasant ride in terms of the daily chart progression over the past couple of years. This is a point witnessed by the decline seen from 130p plus in the autumn of 2013, to a probe below 20p in March. Since then there has been a rehabilitation process, one which has involved higher support points since the spring above 20p, and hen the recovery of the 50 day and 200 day moving averages both currently at 28p. The implication now in the wake of this extended base building is that the bulls should be happy to enjoy the latest golden cross buy signal between the 50 day and 200 day moving averages, with the message being that provided there is no end of day close back below these lines we should be wedded to the buy argument. Just how high the stock could fly over the next 1-2 months is suggested by the top of a rising trend channel, one which has been in place from as long ago as June last year. The best way forward on this basis would be to buy into Aortech International shares on any initial weakness which cools off the overbought RSI, now at 83. - See more at: http://www.shareprophets.com/views/14986/zak-mir-s-great-request-show-aortech-international-ncondezi-energy-petro-matad#sthash.uEAhVqWw.dpufgac141
16/9/2015
08:21
It is great that we no longer seem to be at death's door but we should also not get carried away. The £3 share price of 3 years ago was really down to the value we felt we added to St Jude on the leads which turned out to be a complete illusion. My reading of the last RNS was that in terms of any real data on the heart valve we are back to 1999 almost and that there is a massive amount of work to do and won't any IP protection have lapsed by now? I also have not seen any evidence as you say above that " we are rapidly building turnover" there has been little evidence of new licenses of our technology. I am a lot more confident than I was 12 months ago but lots to do. Let's hope the management team are up to it - the are clearly good at fire fighting but that is a different kettle of fish.harrogate
15/9/2015
10:08
Hi George Whether we get an update on progress at the agm or whether that comes some weeks later I am confident we will get news confirming we are in an exciting new chapter built on solid profitable foundations As you point out people forget that the heart valve did represent a £32 million opportunity and if sold on to a major player after successful in house testing/validation/regulatory approval then this figure could easily double So for a relatively modest outlay (borne by its partner) Aor could be sitting on a gold mine. A JV may be the best way to unlock the potential and ring fence costs while offering a share in future profits As Aor pointed out recently much of the testing has already been successfully carried out for the heart valve and it shows potential to be a world beater particularly due to the very significant cost savings over its rivals Aor highlighted the opportunity at results when it announced it was exploring ways of bringing a team together to develop the value Aor is now profitable and rapidly building turnover and profits from a stable/falling cost base Aor as a loss making Co enjoyed a share price in excess of £3 a couple of years ago and while I agree the share price is only a barometer of sentiment and expectation some of that optimism is now being realised in terms of real profits and opportunity The heart valve is in the share price for free so is the potential £1 mil outcome of the ongoing litigation against Mcguire We have a £2m market cap without the risk and negativity of previous years where we enjoyed a cap in excess of £10m as a loss maker with nil turnover Incredible ! Value will out Great time to be an Aor shareholder imo Best wishes SPspurious
14/9/2015
21:19
I hope you are right.. P I think we may have to be more patient... although any good news could move things very quickly. The building blocks have been put in place.gac141
14/9/2015
20:32
Have to echo your sentiments George. I am hoping the agm this month may provide the ideal opportunity for some positive news. Just as the downside on the share price was greatly exaggerated, the corresponding effect on any positive news will be an equally swift and strong rise I am confident we will see a share price well in excess of £1 in a matter of weeks. Value will outspurious
14/9/2015
16:20
Well said gac141.tadders2
14/9/2015
15:41
Aortech are clearly very much on their feet again and the prospect of insolvency has virtually disappeared. The market cap on this company is ridiculous bearing in mind what they have to offer. Elasteon and its other derivatives are amongst the best products for in body use anywhere in the world. We also have the heart valve which at one point st Jude medical were going to pay 32 million for. Again I congratulate Roy and Eddie for the tireless work they have put in to saving the company from the clutches of despicable businesses and people who were corrupt to the core. I once again look forward to Aortech being a valued company and an excellent asset to my portfolio. Good times ahead.......?gac141
04/9/2015
14:50
Hi Paul I regret selling Ind way too early, albeit at a good profit and well done for being so patient Biomerics relationship is key and for the first time this appears to be working. I am very hopeful we will see the benefits of this shortly in new increased repeat orders for Elasteon. Throw in a possible JV on the heart valve and a company confident in successfully pursuing a million dollar claim and you certainly have the makings of a multi-bagger. Aor enjoyed a share price in excess of £3 in last couple of years while loss making. It is now making profit. I am confident the share price will soon respond Best regards Patrickspurious
04/9/2015
13:54
Hi Patrick, I'm still in IND - 11 years now lol! This is a nice little summary of Aortech, from its most recent results statement: "Despite the time and commitment required in the litigation action, the past year has been one of relative success. Revenue from license fees and royalties are now greater than overheads, the Company was cash positive in the second half of the year, progress is being made with our key licensees and we expect the year 2015/16 to be one of further progress." Not bad for a mkt cap of only about £1.6m. PP.paulypilot
Chat Pages: 131  130  129  128  127  126  125  124  123  122  121  120  >>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20160205 22:04:20